Key result
De-novo acute heart failure was associated with significantly higher mean in-hospital costs (€3678) compared to acute decompensation of chronic heart failure (€2878), largely driven by a greater need for intensive care and interventions.
Observational (n=1,759)
No
Hospitalization costs for acute heart failure are significantly higher for de novo presentations compared to acute decompensations of chronic heart failure, largely driven by the need for intensive care and interventional procedures.
May inform resource planning in de-novo acute HF; leaves open prospective validation of mitigation strategies.
CĂl: StanovenĂ nĂĄkladĹŻ na hospitalizaci pacientĹŻ s akutnĂm srdeÄnĂm selhĂĄnĂm (ASS) hospitalizovanĂ˝ch v letech 2005-2009 na kardiologickĂŠ klinice z pohledu plĂĄtce zdravotnĂ pĂŠÄe a nĂĄslednĂŠ zhodnocenĂ heterogenity vĂ˝dajĹŻ dle etiologie ASS.Metodologie: Typ ASS a jeho etiologie byla urÄena pĹi pĹijetĂ pacienta na kliniku. NĂĄklady na pĂŠÄi vychĂĄzejĂ z individuĂĄlnĂho hospitalizaÄnĂho ĂşÄtu kaĹždĂŠho pacienta (celkem 1 759 pacientĹŻ; 58,7 % muŞů; prĹŻmÄrnĂ˝ vÄk 71 let).VĂ˝sledky: MediĂĄn dĂŠlky hospitalizace pacientĹŻ pro ASS byl 7 dnĂ pĹi prĹŻmÄrnĂ˝ch nĂĄkladech 3 364 € (92 515 KÄ). U 67,4 % pacientĹŻ byl zaznamenĂĄn pobyt na koronĂĄrnĂ jednotce (KJ) po dobu 3 dnĹŻ (mediĂĄn). SignifikantnÄ vyĹĄĹĄĂ nĂĄklady (prĹŻmÄrnÄ 3 678 €; 101 139 KÄ) byly spojeny s hospitalizacĂ pacientĹŻ s novÄ vzniklĂ˝m ASS (tzv. de novo ASS) neĹž u pacientĹŻ s akutnĂ dekompenzacĂ chronickĂŠho srdeÄnĂho selhĂĄnĂ (prĹŻmÄrnĂŠ nĂĄklady2 878 €; 79 154 KÄ; p < 0,001). U pacientĹŻ s de novo ASS byla vyĹĄĹĄĂ potĹeba pobytu na JIP a/nebo KJ, delĹĄĂ pobyt na JIP/KJ a ÄastÄji byly provedeny intervenÄnĂ zĂĄkroky (zejmĂŠna perkutĂĄnnĂ koronĂĄrnĂ intervence - PCI). Dle etiologie ASS byly nejÄastÄji se vyskytujĂcĂ pĹĂÄinou hospitalizace akutnĂ koronĂĄrnĂ syndromy, jeĹž byly zĂĄroveĹ spojeny s nejvyĹĄĹĄĂmi prĹŻmÄrnĂ˝mi nĂĄklady na hospitalizaci (4 429 €; 121 797 KÄ), vyplĂ˝vajĂcĂmi z provedenĂ˝ch PCI u 63,3 % pacientĹŻ a pobytu na KJ u 91,7 % pacientĹŻ. Variabilita dĂŠlky hospitalizace dle etiologie ASS byla minimĂĄlnĂ (mediĂĄn 6-8 dnĂ). K ĂşmrtĂ za hospitalizace doĹĄlo u 15,0 % pacientĹŻ.ZĂĄvÄry: NĂĄklady na hospitalizaci pacientĹŻ s ASS jsou vysokĂŠ, zejmĂŠna u podskupiny s de novo ASS. He-terogenita ve spotĹebÄ zdrojĹŻ je dĂĄna provedenĂ˝mi nĂĄkladnĂ˝mi intervencemi v jednotlivĂ˝ch podskupinĂĄch, zejmĂŠna perkutĂĄnnĂ koronĂĄrnĂ intervencĂ a implantacĂ antiarytmickĂ˝ch zaĹĂzenĂ.
No takes yet. Share an insight, caveat, or question.
Říhová et al. (2012) conducted an observational in Acute heart failure (n=1,759). De-novo acute heart failure vs. Acute decompensation of chronic heart failure was evaluated on Mean total in-hospital costs (p=<0.001). De-novo acute heart failure was associated with significantly higher mean in-hospital costs (€3678) compared to acute decompensation of chronic heart failure (€2878), largely driven by a greater need for intensive care and interventions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: